Nuvation Bio Class A financial statements

누베이션 바이오NYSE:NUVB · New York Stock Exchange · Healthcare · sector #17
$4.86-0.41%
2026-10-07 close

Nuvation Bio Class A's published financial data is dated 2026-10-04. 2024 revenue was $8M. 2024 operating profit was −$593M.

Reported results

Nuvation Bio Class A notifications

Quantus Signal · live data · not investment advice · Privacy Policy